How to Manage Appointments and Patient Records for Psychiatry Practices in 2026

Psychiatry has a workflow problem that most other specialties do not. The visit cadence is long — initial intakes run sixty minutes, med checks run thirty, therapy add-ons stretch sessions to forty-five or sixty, and crisis slots have to live somewhere on the calendar without burning the rest of the day. The no-show economics are punishing: a missed thirty-minute med-management slot is real revenue gone and a real patient drifting off care, and the stigma around psychiatric appointments makes confirmation friction higher than in most specialties. The controlled-substance prescribing audit trail is not optional — every Schedule II-V prescription written from your office runs through EPCS, two-factor identity proofing, and a logged sequence the DEA can pull at any time. Measurement-based care has shifted from research best practice to payer expectation, which means PHQ-9 and GAD-7 scores have to land in the chart before the visit, not after. And telehealth is the default delivery mode, not a bolted-on module — which means scheduling, place-of-service modifiers, and consent tracking all have to default to video and step up to in-person when the clinical picture calls for it.

This guide walks through the workflow that actually holds together: appointment-type design, a no-show defense that compounds, EPCS without ceremony, pre-visit measurement-based care, telehealth-default scheduling with hybrid escalation, the KPIs that tell you whether the operation is healthy, and the mistakes that will quietly cost a small practice a hundred thousand dollars a year if nobody is watching.

Before walking through steps, define the goal state. A psychiatry practice running well in 2026 has a few visible signatures.

Consistent appointment cycles. New patients move from inquiry to scheduled intake in seven to fourteen days. Established patients on stable regimens see their prescriber every four to twelve weeks, depending on medication class and clinical trajectory. The schedule is built so prescribers spend most of their day in billable encounters rather than chasing missed slots.

Near-zero no-shows. A well-run psychiatry practice runs no-show rates in the three-to-eight-percent range, not the fifteen-to-twenty-five-percent range you see when reminders, deposits, and late-cancel policy are absent. The defense is built in layers: forty-eight-hour SMS confirmation, twenty-four-hour re-confirmation, a written late-cancel and no-show fee policy, and a card on file for new patients.

EPCS for every controlled substance. Stimulants, benzodiazepines, sleep agents, buprenorphine — every Schedule II-V prescription flows through Surescripts EPCS with two-factor authentication, identity-proofed prescribers, a PDMP check baked into the workflow, and a controlled-substance audit log that survives any DEA inspection.

Pre-visit measurement-based care. PHQ-9, GAD-7, and other instruments are administered on the patient's phone or on an in-room iPad before the prescriber walks in. Scores are auto-calculated, trended longitudinally, and pulled into the progress note so clinical decision-making references actual data rather than recall.

Telehealth-default with in-person hybrid. New patients book telehealth by default. In-person is offered when the clinical picture calls for it (severe agitation, complex med titration, court-ordered evaluations, certain controlled-substance prescribing rules). Place-of-service modifiers (POS 02 for telehealth, POS 10 for patient-home telehealth, POS 11 for office) flow automatically based on visit type.

Get those five signatures in place and the practice runs. Miss any of them and the workflow leaks revenue and clinician time.

Most psychiatry practices that struggle with scheduling are running too few appointment types or letting them run too long. The right model is five or six visit types, each with a fixed length, a clear billing code, and a clear pre-visit prep list.

Initial intake (60 minutes, CPT 90791 or 90792 with E/M). New patient diagnostic evaluation. Psychiatric history, medical history, medication history, family history, mental status exam, risk assessment, treatment plan, initial prescription if appropriate. Pre-visit: full intake forms, PHQ-9, GAD-7, ROS, ROI for prior records.

Med management (30 minutes, CPT 99213-99214). Established patient, prescriber visit, no formal therapy. Medication review, side effect screen, mental status, refill decisions, dose adjustments. Pre-visit: PHQ-9 and GAD-7 within twenty-four hours of the visit.

Med management with psychotherapy add-on (45-60 minutes, CPT 99213-99214 + 90833 or 90836 or 90838). Same as above plus a documented psychotherapy add-on (16-37 minutes for 90833, 38-52 minutes for 90836, 53+ minutes for 90838). Diagnosis pointers must support both codes on the claim.

Therapy session (45-60 minutes, CPT 90834 or 90837). Therapist-only visit, no medication management component. Often run by an LCSW, LPC, or PsyD on staff.

Brief follow-up (15-30 minutes, CPT 99212-99213). Short check-in for stable patients on long-standing regimens. Quick refill decisions, side effect screens, brief mental status. Useful for patients on maintenance dosing of SSRIs, mood stabilizers, or low-dose stimulants.

Crisis slot (open 30-45 minutes per prescriber per day). Held for urgent escalations — suicidal ideation flare, medication reaction, acute precipitant. Released to the waitlist if unfilled by mid-morning so the slot is not wasted.

The operational rule is that visit types should be color-coded on the calendar and visible at a glance. A scheduler should never have to look up how long a 90833 add-on slot runs — it should be a single click that books the right block at the right code.

No-shows are the single largest preventable revenue leak in psychiatry. A practice running a fifteen-percent no-show rate on $180 med-management slots loses meaningful revenue per prescriber per year. The defense is built in layers, and any single layer in isolation is weak.

Layer 1: Card on file at intake. New patients put a card on file as part of registration. The card is not charged at booking — it sits on file with explicit consent for documented late-cancel and no-show fees. This single change cuts no-show rates faster than any other intervention.

Layer 2: Written late-cancel and no-show fee policy. A typical policy: cancellations within twenty-four hours of the appointment incur a fifty-percent fee; no-shows incur the full visit fee. The exact dollar amount matters less than the policy being written, signed at intake, and enforced consistently. A policy nobody enforces is a policy that does not exist.

Layer 3: Forty-eight-hour SMS confirmation. Two days before the appointment, an automated SMS asks the patient to confirm or reschedule. The text should include date, time, prescriber name, and a single tap to confirm or call to reschedule. Patients who cannot make the appointment will surface here, and the slot can be rebooked from the waitlist.

Layer 4: Twenty-four-hour re-confirmation. A second SMS the day before functions as a final reminder. Patients who confirm at this stage rarely no-show.

Layer 5: Waitlist fill. When a slot opens (cancellation or no-show within reach of next-day booking), an automated SMS goes out to the waitlist offering the slot. The first patient to claim it gets the appointment. This converts a lost slot into a filled slot in many cases.

Layer 6: Deposit for new patients. A modest deposit (often $50-100) at intake booking, refundable on attendance, dramatically cuts new-patient no-show rates. New patient no-shows are particularly costly because they consume a sixty-minute initial intake slot.

Layered together, these moves take a fifteen-percent no-show rate and bring it under six percent. The revenue recovery is substantial.

Electronic prescribing of controlled substances is no longer a nice-to-have. Federal law and most state laws now mandate EPCS for nearly all controlled-substance prescriptions, with paper exceptions narrowing year over year. For a psychiatry practice prescribing stimulants, benzodiazepines, sleep agents, or buprenorphine, EPCS is the operational baseline.

What EPCS actually requires.

*Identity proofing.* The DEA requires that each EPCS prescriber be identity-proofed by an approved credential service provider before issuing controlled-substance prescriptions electronically. This is a one-time setup but it is not skippable — a prescriber who has not been identity-proofed cannot legally e-prescribe controlled substances, even with a valid DEA number.

*Two-factor authentication at the moment of signing.* Every controlled-substance prescription requires a two-factor signing event — typically a hard token, a soft-token mobile app, or a biometric factor combined with a passphrase. The two factors must come from at least two of the three categories (something you know, something you have, something you are). The signing event is logged with timestamp, factors used, and prescription details.

*EPCS-certified vendor.* The e-prescribing software must be certified for EPCS by an approved third-party auditor. Surescripts and most major EHR vendors maintain EPCS certification — but always confirm current certification status with the vendor before signing.

*PDMP check workflow.* Most states require prescribers to query the prescription drug monitoring program (PDMP) before issuing certain controlled-substance prescriptions. The workflow should make the PDMP check one click, not a separate browser tab and a separate login.

*Audit trail.* Every controlled-substance prescription event — initiation, signing, transmission, modification, cancellation — is logged in an immutable audit trail. The audit log must be retrievable on demand for DEA review.

Why this matters operationally. A practice with EPCS done right can issue a controlled-substance prescription in under two minutes from the chart, including the PDMP check. A practice without it loses ten to fifteen minutes per controlled-substance prescription to paper workarounds, fax workflows, and pharmacist callbacks. Multiplied across thirty to fifty controlled-substance prescriptions per prescriber per week, the time difference is substantial.

Measurement-based care has moved from optional best practice to standard of care. Commercial payers and value-based programs increasingly expect PHQ-9 and GAD-7 scores tied to depression and anxiety claim submissions. More importantly, scoring instruments before the visit improves clinical decisions: trends are easier to read than recall, and patients are more honest on a screen than in conversation.

The instruments to administer routinely.

*PHQ-9.* Nine-item Patient Health Questionnaire for depression. Score 0-27. Cutoffs: 0-4 minimal, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe. Standard instrument for any patient with a depressive disorder or being screened for one.

*GAD-7.* Seven-item Generalized Anxiety Disorder scale. Score 0-21. Cutoffs: 0-4 minimal, 5-9 mild, 10-14 moderate, 15-21 severe. Standard for anxiety disorders and depression patients with comorbid anxiety.

*MADRS.* Montgomery-Asberg Depression Rating Scale. Ten-item clinician-administered (or self-report version) often used in research settings and treatment-resistant depression workflows.

*YMRS.* Young Mania Rating Scale. Eleven-item clinician-administered scale for bipolar disorder mania assessment.

*AUDIT.* Ten-item Alcohol Use Disorders Identification Test. Useful in dual-diagnosis and substance-using populations.

*PCL-5.* Twenty-item PTSD Checklist for DSM-5. Standard for PTSD screening and tracking.

*ASRS.* Adult ADHD Self-Report Scale. Eighteen-item screen for adult ADHD evaluation.

The workflow that works.

Twenty-four to forty-eight hours before each scheduled visit, the patient receives an SMS or email link to the relevant instrument. PHQ-9 and GAD-7 take three to five minutes combined. The patient completes the instrument on their phone before walking in (or before the telehealth call). Scores auto-calculate, drop into the chart, and trend longitudinally so the prescriber sees the trajectory at a glance.

When the prescriber opens the chart at the start of the visit, the most recent PHQ-9 and GAD-7 scores are visible alongside the prior six months of scores. Treatment decisions reference the data: 'PHQ-9 dropped from 18 to 11 since adding sertraline 100mg six weeks ago, continue current regimen.' The progress note pulls the scores in automatically.

The alternative — handing a paper PHQ-9 to the patient in the waiting room and tallying it by hand — wastes clinical time and produces a chart that does not trend. The pre-visit digital workflow is meaningfully better in every dimension.

Psychiatry has stayed telehealth-dominant well after the pandemic-era reimbursement spike, and the operational implication is that scheduling should default to telehealth and step up to in-person when clinical judgment calls for it.

Default to telehealth at booking. New-patient online booking and established-patient self-scheduling should default the visit type to telehealth. Patients who specifically need in-person can select it manually. This single setting shifts the practice mix toward video and reduces friction for patients in geographic, mobility, or scheduling constraints.

In-person triggers. A handful of clinical situations should escalate to in-person — severe agitation that needs in-room observation, complex med titration where physical exam matters (lithium levels with tremor monitoring, vital signs for stimulant titration, weight checks for atypical antipsychotics), court-ordered evaluations, certain initial controlled-substance evaluations where state law or practice policy requires in-person, and patients who clinically benefit from the physical-room therapeutic frame.

Place-of-service modifiers handled correctly. Telehealth visits use POS 02 (other site) or POS 10 (patient home), depending on the patient's location at the time of the visit. In-person visits use POS 11. The wrong modifier on a claim triggers denial, and a practice that forgets POS 10 for home-telehealth visits during the post-COVID flexibility windows can leave meaningful revenue uncollected. The platform should auto-set the modifier based on visit type.

Consent for telehealth. Most states require documented consent for telehealth at the first visit and at periodic re-affirmations. The platform should collect electronic signatures on telehealth consent at intake and store them in the chart.

Connection failure protocol. Have a written protocol for what happens if the video session fails — fall back to phone, reschedule, complete the visit by phone with documentation. Clinicians who do not have a written fallback waste clinical time troubleshooting Wi-Fi.

Multi-state licensing. Telehealth-default practices often see patients in multiple states. Each prescriber must be licensed in the state where the patient is physically located at the time of the visit. The PSYPACT compact has eased this for psychologists in participating states; psychiatrists must still individually license in each state. A scheduler should confirm patient location matches a state where the prescriber holds licensure before booking.

Psychiatry practice analytics tend to either be absent (operations run on intuition) or buried in clinical-research dashboards that nobody reads. The tractable approach is a short list of operational KPIs reviewed weekly.

No-show rate. Total no-shows divided by scheduled appointments, by prescriber and overall. Healthy psychiatry practices run three-to-eight percent. Above ten percent indicates a broken reminder or fee-policy workflow.

Late-cancel rate. Cancellations within twenty-four hours, divided by scheduled appointments. Healthy practices run five-to-ten percent. Tracks separately from no-shows because the slot is recoverable from the waitlist.

Time to third-available appointment. The number of days until the third-available open slot for a given prescriber. Industry-standard psychiatry capacity metric. New patients should be reachable within fourteen days for healthy access; sustained values above thirty days indicate the practice is at or beyond capacity.

Completion rate of measurement instruments. Percentage of scheduled visits with a PHQ-9 or GAD-7 completed in the prior forty-eight hours. Healthy measurement-based care practices run eighty-percent-plus completion. Below sixty percent indicates the pre-visit reminder workflow is broken or patients are not engaging with the link.

Visit completion by prescriber. Total billable visits per prescriber per week. Useful for spotting capacity issues, schedule gaps, and prescriber burnout signals.

Controlled-substance audit completeness. Percentage of controlled-substance prescriptions with a documented PDMP check in the prior thirty days. Should be one hundred percent.

Days in accounts receivable. Average days from claim submission to payment. Healthy psychiatry practices run thirty-to-forty-five days. Above sixty days indicates a billing or denial-management problem.

Net collection rate. Total payments divided by total expected payments after contractual adjustments. Healthy practices run ninety-five-percent-plus. Below ninety percent indicates billing follow-up is leaking revenue.

Review these eight numbers weekly. Most practices will surface their largest operational problem within thirty days of starting the discipline.

Deelo is an all-in-one operating system for service businesses, and the Practice app is the HIPAA-grade clinical surface for psychiatry, therapy, and behavioral-health practices. The pieces relevant to the workflow above:

Practice app. HIPAA-grade encrypted patient records, configurable visit types, multi-prescriber and multi-room scheduling, color-coded calendar with visit-type at a glance, telehealth-default booking with in-person hybrid, electronic intake forms, ROI tracking, and supervisor co-signature workflow for residents and supervised PMHNPs.

Bookings. Online self-booking with required deposits for new patients, configurable appointment-type lengths, recurring appointment blocks for established patients, waitlist with auto-fill on cancellation, and forty-eight-hour and twenty-four-hour automated reminders by SMS and email.

Marketing automation. Pre-visit instrument links (PHQ-9, GAD-7, PCL-5) sent twenty-four to forty-eight hours before each scheduled visit, with results auto-routed into the chart.

Invoicing and Subscriptions. Card on file at intake, late-cancel and no-show fee enforcement against the stored card, package billing for therapy series, and monthly billing for cash-pay subscriptions.

Compliance. HIPAA-grade encryption at rest and in transit, role-based access, full audit logs of PHI access and edits, and exportable audit trails for regulatory review.

Pricing. Free for individuals. Starter at $19 per seat per month. Business at $39. Enterprise at $69. A solo prescriber runs the full operation at $19 per month; a four-prescriber group with two therapists and two front-desk staff runs at roughly $156 per month on Starter.

What Deelo does not do natively: EPCS itself. Controlled-substance e-prescribing requires an EPCS-certified vendor with identity-proofing, two-factor signing, and PDMP integration. Most psychiatry practices on Deelo run an EPCS-certified e-prescribing tool (DoseSpot, NewCrop, RxNT, or a comparable Surescripts-connected vendor) alongside Deelo for the prescribing layer, and use Deelo as the operating layer for everything else — scheduling, charting, billing, measurement-based care, and patient communication. Confirm current EPCS certification status and integration capability with any vendor before signing a contract.

For practices that want a single bill and a single login for the operating layer rather than ten subscriptions stitched together, the math compounds. The largest savings are not the per-seat sticker price — they come from killing the seven-tab workflow that wastes clinical time.